| ²é¿´: 297 | »Ø¸´: 0 | ||
ʯͷVS¹¬³Ç½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
ÓдóÉñÖ¸µ¼Ò©ÎïµÄPK·¶Î§ÓëÒ©Îï´úл֮¼äµÄ¹ØÏµÂð£¿
|
|
The authors should evaluate PK profile of cpd 21. This is critical to validate their speculation of possible metabolite 34 even calculated by in silico software. ÂÛÎÄͶ¸åʱ£¬Éó¸åÈËÀ´ÁËÕâÑùÒ»¸öÎÊÌâÄØ£¬°Ù˼²»µÃÆä½â£¬Çó°ïÖú£¡ |
» ²ÂÄãϲ»¶
26µ÷¼Á 086003
ÒѾÓÐ3È˻ظ´
265Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
271·ÖÇóµ÷¼ÁѧУ
ÒѾÓÐ11È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á£¬Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ8È˻ظ´
280Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
Çó²ÄÁϵ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ289·Ö
ÒѾÓÐ15È˻ظ´
26¿¼Ñе÷¼Á0710 0860
ÒѾÓÐ6È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ22È˻ظ´
283Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´















»Ø¸´´ËÂ¥